Caenorhabditis elegans as research animal model

Authors

  • Elena Caldero-Escudero , Estudiante de Doctorado en Investigación Biomédica, Instituto de Biomedicina y Genética Molecular, Universidad de Valladolid y CSIC, España. https://orcid.org/0009-0000-0694-3243
  • Silvia Romero-Sanz , Estudiante de Doctorado en Investigación Biomédica, Instituto de Biomedicina y Genética Molecular, Universidad de Valladolid y CSIC, España. https://orcid.org/0000-0003-4671-7376

DOI:

https://doi.org/10.24197/cl.29.2024.67-69

Keywords:

BASIC RESEARCH, c.elegans, research animal model, basic research

Abstract

Caenorhabditis elegans (C. elegans) is a non-parasitic nematode widely used as an animal model in scientific research. It is a multicellular organism with simple tissues and anatomy, reaching a fixed number of cells in its adult stage, 959, of which 302 are neurons [1]. It is precisely its simplicity that gives it great value as an animal model. The simplicity of this nematode facilitates the understanding of complex cellular signaling pathways in mammals, such as neurodegenerative processes, the biochemical mechanisms of which in more evolved animals remain a subject of debate [2]. Furthermore, the genome of C. elegans is completely sequenced, making it a powerful tool for genetic studies, as more than 60% of its genes are orthologous to human disease genes [3]. Other advantages of its use in research include its easy handling, small size (1 mm in adulthood), high brood size, short life cycle (20 days), transparency, and modest economic costs. Due to these advantages, C. elegans is widely used in various research fields such as genetics, development, metabolism, neurodegeneration, and aging, among others [4-8]. C. elegans is a powerful tool in the development of basic research that undoubtedly supports clinical research, providing simple and effective models for the study of complex biological processes, human diseases, and potential treatments.

Downloads

Download data is not yet available.

References

(1) Ruszkiewicz JA, Pinkas A, Miah MR, et al. C. elegans as a model in developmental neurotoxicology. Toxicol Appl Pharmacol. 2018;354:126-135. doi:10.1016/j.taap.2018.03.016

(2) Caldero-Escudero E, Romero-Sanz S, De la Fuente S. Using C. elegans as a model for neurodegenerative diseases: Methodology and evaluation. Methods Cell Biol. 2024;188:1-34.

(3) Corsi AK, Wightman B, Chalfie M. A Transparent window into biology: A primer on Caenorhabditis elegans. In: WormBook: The Online Review of C. elegans Biology [revista en Internet]. Pasadena (CA): WormBook; 2005-2018. [ acceso 26 de agosto de 2024 ] Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK299460/

(4) Romero-Sanz S, Caldero-Escudero E, Álvarez-Illera P, et al. SERCA inhibition improves lifespan and healthspan in a chemical model of Parkinson disease in Caenorhabditis elegans. Front Pharmacol. 2023;14:1182428. Published 2023 May 22.

(5) Markaki M, Tavernarakis N. Caenorhabditis elegans as a model system for human diseases. Curr Opin Biotechnol. 2020;63:118-125.

(6) Weiser A, Hermant A, Bermont F, et al. The mitochondrial calcium uniporter (MCU) activates mitochondrial respiration and enhances mobility by regulating mitochondrial redox state. Redox Biol. 2023;64:102759.

(7) Alvarez J, Alvarez-Illera P, Santo-Domingo J, Fonteriz RI, Montero M. Modeling Alzheimer's Disease in Caenorhabditis elegans. Biomedicines. 2022;10(2):288. Published 2022 Jan 26.

(8) Yue Y, Li S, Shen P, Park Y. Caenorhabditis elegans as a model for obesity research. Curr Res Food Sci. 2021;4:692-697.

Downloads

Published

2024-10-10

Issue

Section

Imágenes/Infografías